abstract |
The present invention relates to compounds having the following Formula: (see Formula) or a stereoisomer or a pharmaceutically acceptable salt thereof, wherein R2 is a monocyclic heteroaryl group, and R1, R3, R4, R5 and R6 as defined herein, they are useful as kinase modulators, which includes the inhibition of IRAK-4. |